An initiative to establish MDKメディカル and develop healthcare as a new earnings pillar through investments in overseas medical device startups and the acquisition of exclusive distribution rights in Japan. This also includes the possibility of uncollectible receivables resulting from clinical trial delays and investment-related losses.